Introduction
The cytokine IL-12 is a pro-inflammatory agent that can be (6-8). The production of IL-12 is induced by microbial signals such as lipopolysaccharide (LPS) or CpG bacterial DNA used as a potent vaccine adjuvant in infectious disease and cancer models due to its ability to stimulate cellular immunity motifs (9,10), by activated T cell signals mediated by CD40-CD40 ligand (CD40L) (11), and further regulated by cytokines (reviewed in 1). Targeted or natural mutations occurring in IL-12 or in the components of its receptor have underscored such as IFN-γ, IL-4 and granulocyte macrophage colony stimulating factor (GM-CSF) (12,13). While bacterial products the importance of this cytokine in the control of IFN-γ production by T and NK cells, in the development of T h 1 T cell are able to induce IL-12 secretion on their own, stimulation with CD40L is not very effective unless provided in conjunction responses, and in the resistance to infections by intracellular organisms (2-4). Phagocytes and antigen-presenting cells, with . Recent studies suggest that cross-linking of CD40 be accompanied by a microbial priming signal to result including dendritic cells (DC), produce IL-12 (5). As DC form intimate contacts with lymphocytes, notably with naive T cells, in the secretion of detectable levels of IL-12 in vivo (15). This underscores the requirements for accessory signals allowing the mechanisms that regulate IL-12 production in DC are central to the study of lymphocyte activation and T cell IL-12 production in the context of T cell-DC interactions. Some of our preliminary experiments showed that DC development. The pro-inflammatory IL-12 molecule is a secreted disulfide linked heterodimer of 70 kDa comprising produced in, or exposed, to a specific cocktail of cytokines produced more IL-12β in response to CD40L than mature an α and a β subunit (previously referred to as p35 and p40 chains respectively). Separate mechanisms regulate the DC, suggesting that some of these cytokines could play an accessory function with CD40L. DC produced by culture of production of the two IL-12 chains as well as the secretion of the IL-12 heterodimer both at the transcriptional and posthematopoietic progenitor cells in the presence of flt3 ligand, c-kit ligand, GM-CSF, IL-1β and IL-7 (FKGm17) (16) produced translational levels, indicating that IL-12 production is tightly controlled and susceptible to regulation by multiple factors more IL-12β after stimulation with CD40L and induced higher levels of IFN-γ production by T cells in a mixed lymphocyte Immuno-staining and flow cytometric analysis reaction than mature DC generated from the same hematoFor cell surface antigen detection, cells were washed in poietic progenitor cells in the presence of flt3 ligand, c-kit staining buffer (PBS, 0.2% BSA, 0.02% sodium azide) and ligand, GM-CSF, tumor necrosis factor (TNF)-α and IL-4 incubated for 10 min on ice with excess human γ-globulin (FKGmT4) (17) (18) (19) . IL-1β was tested as a possible candidate
(1 mg/ml in staining buffer; Gamimune, Miles, Eckhert, IL) to molecule that could induce IL-12 due to potential analogy of block non-specific Fc binding prior to incubation with directly signaling pathways between members of the IL-1 receptor conjugated mAb such as CD83-phycoerythrin (PE) (Coulterand the toll-like receptor superfamily. Ligands for toll-like Immunotech), HLA-DR-FITC, CD54-PE (Caltag) and CD86-receptors, such as LPS and bacterial lipoproteins, have been FITC (BD-PharMingen). After two washes in staining buffer, reported to induce IL-12 in DC (14, 20) . Results show that propidium iodide (Sigma; 5 µg/ml) was added to permit IL-1β is a major inducer of IL-12β production and of IL-12 αβ exclusion of dead cells by flow cytometry. heterodimer secretion in DC in conjunction with CD40L, and For intracellular staining, cells were washed in PBS then that the effects of IL-1β differ from those of LPS and synergize fixed for 5 min in 4% formaldehyde, washed twice in PBS with IFN-γ to induce very high amounts of IL-12 secretion.
and permeabilized by one wash in a 0.1% saponin (Sigma) solution in staining buffer. Non-specific Fc binding was blocked by incubation for 10 min on ice with 1 mg/ml Methods Gamimune in saponin buffer, then cells were incubated for 30 min on ice with mAb diluted in saponin buffer followed by Source of cells two washes in saponin buffer. Cells were resuspended in staining buffer prior to analysis. FITC-conjugated anti-IL-12 Human blood samples were obtained with approval from the (BD-PharMingen), which recognizes the IL-12 β chain either Institutional Review Board of Wayne State University. Blood alone or in IL-12 α/β heterodimer, was used for detection of from normal adult volunteers was obtained from buffy coats intracellular IL-12β in DC, while PE-conjugated anti-IL-10 prepared at the American Red Cross (Detroit, MI). Granulocyte (BD-PharMingen) was used for measuring intracellular IL-10. colony stimulating factor (G-CSF)-mobilized peripheral blood Irrelevant control mAb were used as negative controls of nonwas obtained from breast cancer patients at the Karmanos specific staining. Cells were analyzed on a FACSCalibur Cancer Institute. Mononuclear cells (MNC) were isolated instrument (Becton Dickinson) and data were analyzed using by centrifugation over Ficoll (Amersham Pharmacia Biotech, WinMDI (version 2.8) software. Piscataway, NJ) (d Ͻ 1.077 g/ml) and were cryopreserved in liquid nitrogen using a 10% DMSO freezing solution.
ELISA Culture of DC
Cytokines were measured in supernatants using the OptEIA ELISA kit for IL-12p70 and OptEIA ELISA set for IL-10 accordAdherent monocytes were obtained by incubating MNC on ing to the manufacturer's instructions (BD-PharMingen). The tissue culture plates (2ϫ10 6 cells/ml/well in 24-well plates) in lower limit of detection for each was 4 pg/ml. RPMI medium with 10% FBS (R10) (18) in a humidified atmosphere for 2 h. After removing non-adherent cells by
Blocking with neutralizing antibodies gentle washes, adherent monocytes were induced to differentiate into DC by incubation at 37°C, 5 % CO 2 , in the presence of For blocking experiments, neutralizing antibodies were added several combinations of cytokines and R10 medium. Cytokines at the start of stimulation with CD40L or IL-1β (10 ng/ml). included GM-CSF (Immunex, Seattle, WA), TNF-α (RDI, Goat anti-human neutralizing IgG specific for IL-1β and IFNFlanders, NJ; 50 U/ml), IL-4 (kind gift from Dr H. Yssel, DNAX γ (R & D Systems) were used at 1 and 25 µg/ml respectively Research Institute, Palo Alto, CA; 100 U/ml) and IL-1β (R & D for blocking. Normal goat IgG (Jackson ImmunoResearch, systems, Minneapolis, MN; or NCI, Biological Resource West Grove, PA) was used at 25 µg/ml as a control. Branch Repository, Rockville, MD; various concentrations).
Non-isotopic RNase protection assay (RPA) Activation of DC with cytokines or CD40L
Total RNA was isolated using RNA Isolator (Sigma-Genosys, The Woodlands, TX) from day 6 DC treated with and without After 4-10 days of culture in the presence of indicated cytokines, cells were harvested and washed twice in cytokine-CD40L (1 µg/ml) and IL-1β (10 ng/ml) for 6-8 h. Biotin-labeled RNA probes were transcribed from PharMingen's Multi-Probe free medium, prior to incubation at the concentration of 2ϫ10 5 to 10 6 DC/ml of R10 medium with indicated stimuli such as: template set using the Maxiscript transcription kit (Ambion, Austin, TX) with T7 RNA polymerase and biotin-14-CTP (Gibco/ IL-1β (various concentrations), human recombinant CD40L (Immunex; 1 µg/ml), LPS (Sigma, St Louis MO; 100 ng/ml) BRL, Rockville, MD) used at a 40:60 ratio with unlabeled CTP. RPA were performed using Ambion's RPA III kit according to and IFN-γ (R & D Systems; 100 ng/ml). For measures of intracellular contents of IL-12, monensin (Sigma; 2 µM) was the manufacturer's instructions. Briefly, sample RNA was hybridized to 4 ng biotin-labeled probes overnight at 56°C, added to the DC culture for the last 5 h. For measuring IL-12 secretion by ELISA, supernatants were collected and stored then digested with RNase A/T. Digested probes were analyzed on a 8 M urea/5% polyacrylamide gel (19:1acrylamide:bisfrozen at -20°C until tested. Endotoxin levels in working concentrations of cytokines, media and CD40L were deteracrylamide) (BioRad, Hercules, CA) in TBE. Separated probes were transferred to a positively charged nylon membrane by mined to be Ͻ0.01 ng/ml by Limulus amoebocyte lysate gel assay (Sigma).
an electroblotter, UV cross-linked (Stratagene, La Jolla, CA), RNA (Ambion) for 25 cycles (1 min 95°C, 2 min 57°C, 1 min 70°C). Competitive inhibitors to 18S RNA were included at a 4:1 ratio of competimers:primers. PCR products were separated on a 2% agarose gel, stained with ethidium bromide and images were analyzed on the Kodak Image Station. Levels of IL-12α mRNA were expressed as ratio of signal intensity relative to 18S RNA.
Results

Effects of IL-1β on the induction of IL-12 production in DC
Preliminary results showed that progenitor cell-derived DC cytes respectively in the presence of GM-CSF and IL-4 or in the presence of cytokine cocktails containing TNF-α, GM-CSF and IL-4 (18). Both mature and immature cells expressed DC markers such as CD40 and HLA-DR. However, while then subjected to chemiluminescent detection using Ambion's BrightStar Biodetect kit with CDP-Star substrate.
immature DC did not express detectable CD83 at any time point examined, CD83 was found in 34% of mature DC by Image analysis was performed using the Kodak Image station 440 CF and 1D Image Analysis software. Results are day 4. Mature and immature DC were subsequently activated for 24 h with IL-1β and/or CD40L to measure IL-12 production. expressed as the ratio of signal intensity for IL-12 β mRNA levels relative to mRNA levels for the L32 gene.
The induction of intracellular IL-12β was measured by flow cytometry. In either type of DC, IL-12β was at background Relative quantitative RT-PCR levels without CD40L stimulation but was induced after CD40L stimulation (Table 1) . In mature DC, statistically higher IL-12β RNA prepared from DC as described above was incubated with MMLV reverse transcriptase (Promega, Madison, WI) and was obtained after stimulation with CD40L and IL-1β (10 ng/ml) compared to CD40L alone in spite of tissue random hexanucleotide primers for 1 h at 37°C. The resulting cDNA was amplified by PCR using AmpliTaq DNA polymerase variations, commonly observed with human samples (Table  1) . In immature DC IL-1β had no significant effect on levels [Applied Biosystems (PE Corp), Foster City, CA] and a multiplex PCR kit with primers for IL-12α and 18S ribosomal of IL-12β at the dose tested of 10 ng/ml. The secretion of the heterodimer IL-12αβ, representing the biologically active proinflammatory form of IL-12, was measured by ELISA in supernatant fluid. Under the experimental conditions, stimulation with CD40L alone induced low, albeit detectable, levels of IL-12 heterodimer in either type of DC. Levels were higher in immature DC, thus confirming reports that TNF-α-induced maturation diminished the capacity of DC to secrete IL-12 in response to CD40L (21) . Addition of IL-1β to CD40L produced a significant increase in IL-12 secretion, of~10-fold in mature DC and~14-fold in immature DC over that induced by CD40L alone. Treatment with IL-1β alone, in the absence of CD40L, did not induce IL-12 secretion. While most of these experiments were performed with DC derived from G-CSF-mobilized peripheral blood, we also confirmed these same effects of that immature DC produced by culture of monocytes with GM-CSF and IL-4 for 6 days produced the highest levels of IL-12 in response to CD40L (data not shown). Therefore, these cells were used to test the effects of various concentrations of IL-1β on the intracellular production and secretion of IL-12.
High concentrations of IL-1β (Ͼ30 ng/ml) were required to increase IL-12β levels above those induced by CD40L alone (Fig. 1) , thus confirming that a concentration of 10 ng/ml such as used in Table 1 would have no additional effect on IL-12β levels induced by CD40L in immature DC. In contrast, lower concentrations of IL-1β controlled secretion of the heterodimer, with a dose-dependent effect initiated Ͼ0.3 ng/ml and plateauing at 30 ng/ml. Thus IL-1β has a dose-dependent 
IL-1β shortens induction time for IL-12 and is required for maximal IL-12 heterodimer secretion
The dissociation observed between the effects of IL-1β on intracellular and secreted levels of IL-12 prompted us to Maturation effects of IL-1β analyze the kinetics of production of these two molecular
The immature state of DC coincides with the high production forms. Using day 6 immature DC, we measured IL-12 producof IL-12 therefore we tested the possibility that IL-1β might tion at 8, 16, 24, 48 and 72 h after stimulation with IL-1β and/ induce IL-12 by impairing DC maturation. Maturation state or CD40L. In response to CD40L stimulation alone, DC was evaluated by the expression of cell surface markers such produced intracellular levels of IL-12β which peaked on or as CD54 (ICAM-1) and CD86 which are up-regulated on after 24 h post-stimulation (Fig. 2) . We detected very little DC during the CD40L-induced maturation process (Fig. 3) . IL-12 heterodimer in the supernatant after CD40L stimulation
Results showed that IL-1β treatment induced higher levels of in agreement with data presented in Table 1 . Addition of these molecules on DC and did not inhibit the maturation IL-1β to CD40L treatment caused a shift in IL-12β accumulainduced by CD40L, thus confirming reports that IL-1β is a tion, which peaked earlier, at 16 h post-stimulation. A sharp maturation factor for DC (22) . In all experimental conditions rise in secreted IL-12 heterodimer was detected at 24 h tested here, DC expressed equivalent and high levels of cell (42.2 pg/1000 cells), with peak production at 48 h postsurface HLA-DR (Fig. 3) and MHC class I antigens (data not stimulation (105.9 pg/1000 cells) that persisted for at least 72 h shown). The functional maturation state was confirmed in (86.2 pg/1000 cells). Thus, IL-1β accelerated the induction of mixed lymphocyte assays showing that DC treated with IL-12 β chain and dramatically augmented the secretion of IL-1β with or without CD40L induced higher T cell proliferation than immature DC (data not shown). We conclude that the bioactive IL-12 heterodimer. the effects of IL-1β and CD40L were not indirectly caused by IFN-γ which can be produced by some DC (24) . Thus, IL-1β has direct and specific effects on DC, and its mechanism of action is distinct from that of IFN-γ, with which it synergizes to induce even higher levels of IL-12 secretion.
Differential effects of LPS and IL-1β on DC cytokines
LPS, which is known to regulate IL-12 production, is a common laboratory contaminant, but measurements of endotoxin levels Fig. 4 . IL-1β synergizes with CD40L and IFN-γ for high levels of in cytokines and culture media suggested that the effects of IL-12 secretion. Immature DC prepared as in Fig. 1 were co-treated IL-1β were not due to the presence of LPS. In fact, LPS had with CD40L, IL-1β (10 ng/ml) and IFN-γ (100 ng/ml) for 24 h, and the levels of IL-12 heterodimer were measured in the supernatant by biological activities distinct from IL-1β in our system. Immature ELISA. Results are shown as the average of three independent DC were treated for 24 h with LPS (100 ng/ml), CD40L and experiments with different tissues and error bars represent SD.
IL-1β in various combinations, and IL-12 was measured. Neither LPS nor IL-1β used as single agents induced IL-12 production but the association of these two stimuli induced the production of IL-12β and the secretion of IL-12 heterodimer in small amounts (Fig. 6 ). In the presence of CD40L, IL-12β was produced, but the heterodimer was not secreted unless LPS or IL-1β was included and together they had an additive effect on CD40L-induced secretion of IL-12. These flow cytometric data were confirmed by an alternate method, using an ELISA to detect IL-12β production in culture medium (data not shown).
A major difference between IL-1β and LPS was found in the regulation of IL-10. Treatment of DC with LPS with CD40L Immature DC prepared as in Fig. 1 were treated with CD40L and IL-1β (10 ng/ml) in the presence of neutralizing antibodies to IFN-γ and CD40L did not (Fig. 6) . ELISA measurements confirmed (25 µg/ml), IL-1β (1 µg/ml) or irrelevant control IgG (25 µg/ml). and LPS (64.4 Ϯ 0.4 pg/1000 cells), whereas cells treated with CD40L and IL-1β produced very little IL-10 (7.8 Ϯ 0.2 pg/1000 cells). To determine the cellular source of IL-12 and IL-10, we performed a correlated two-color flow mechanism for inducing high levels of IL-12 by IL-1β is not due to an inhibition of maturation. cytometric analysis. Results indicated that IL-10-PE labeled cells were distinct from IL-12-FITC-labeled cells (Fig. 6D) .
Effects of IL-1β are distinct from those of IFN-γ and are
This suggests that monocyte-derived DC populations are not specifically blocked by neutralizing antibodies functionally homogeneous and that certain stimuli, CD40L with LPS in this case, may prompt antagonistic functions IFN-γ is a co-inducer of IL-12 that is known to up-regulate the transcription of the IL-12α and IL-12β genes in human blood among subsets of DC. The effects of IL-1β and LPS were further compared in the MNC in response to LPS (6,23). IFN-γ also allows CD40L to induce IL-12 secretion (14). This prompted us to compare presence of IFN-γ, which is known to increase the production of IL-12 in response to LPS (14, 25) . Prior studies have shown the effects of IFN-γ with those of IL-1β and to examine the effects of combining these two cytokines with CD40L. Based that IFN-γ 'primes' human blood mononuclear cells to respond to LPS and that a pre-incubation of~24 h is optimal to induce on the analysis of three separate blood sample donors, we confirmed that co-treatment of DC with CD40L and either the secretion of high levels of IL-12 in response to LPS (6). We herein primed immature DC with IFN-γ overnight and then IL-1β or IFN-γ induced IL-12 heterodimer secretion, whereas treatment with CD40L alone did not (Fig. 4) . We note that stimulated these DC with various stimuli. Un-primed DC were included for comparison, and in such cells, secretion of IL-1β or of IFN-γ were used at optimal concentration (data not shown for IFN-γ), indicating similar amplitude of potency IL-12 was not induced by CD40L, but required CD40L and IL-1β co-treatment (Fig. 7) . When primed with IFN-γ, IL-12 for these two cytokines. When used in combination, CD40L, IFN-γ and IL-1β synergized to induce high levels of IL-12 was produced and secreted in response to either CD40L or LPS. Unlike LPS, IL-1β alone was not able to induce IL-12β which were~7-fold greater than levels induced by CD40L with optimal doses of either IFN-γ or IL-1β.
production or IL-12α/β secretion after IFN-γ priming ( Fig. 7A  and B ). CD40L and IL-1β synergized with IFN-γ priming to The effects of IL-1β were specific. Neutralizing antibodies to IL-1β, but not irrelevant antibodies, abolished IL-12 secretion induce high levels of IL-12. IFN-γ priming and treatment with CD40L plus IL-1β induced 80 pg IL-12/1000 cells, which when added to cultures of DC stimulated with IL-1β and CD40L (Fig. 5) . In the same experiment, anti-IFN-γ antibodies appeared to be 2 times higher than when the three stimuli were used contemporaneously (~40 pg/1000 cells in Fig. 4) . were unable to block the secretion of IL-12 thus showing that The addition of anti-IFN-γ antibodies at the time of priming abolished the effect of IFN-γ on both IL-12β production and IL-12 secretion (Fig. 7A and B) . Blocking IFN-γ also shows that the effects of CD40L and IL-1β do not require the presence of endogenous IFN-γ. Blocking IL-1β slightly diminished the amounts of IL-12 induced by LPS suggesting that endogenous IL-1β may be partially involved in the response to LPS. Endogenous IL-1β was not required for CD40L-induced secretion after IFN-γ priming. Altogether, our results show that IL-1β and LPS act as co-inducers of IL-12 with CD40L but that their mechanisms of action are distinct. They differ based on IL-10 induction and responses to IFN-γ priming. The stimulation of DC with IL-1β and CD40L constitutes a powerful signal that induces the production of high levels of IL-12α/β with little IL-10. It synergizes with IFN-γ, leading to the secretion of very high levels of IL-12.
Effect of CD40L and IL-1β on IL-12 gene expression
Production of IL-12 heterodimer is dependent on the expression of two separate genes. Levels of IL-12α mRNA appear to be constitutively present in many cells, whereas IL-12β experiments, data not shown). DC treated with CD40L alone
IL-1β induces DC to produce IL-12 1059
new example for the regulation of IL-12 by signaling through members of the IL-1-receptor/toll-like receptor superfamily (9, 14, 20) . The biological activities of IL-1β were distinguished from those of LPS, a ligand for toll-like receptor 4 by the following observations: unlike LPS, IL-1β required CD40L to induce IL-12 secretion and IL-1β was unable to induce IL-12 solely in response to IFN-γ priming; unlike LPS, IL-1β did not induce high levels of IL-10. This suggests that differential signaling through various members of the IL-1 receptor /tolllike receptor superfamily might be involved in the differential and complex regulation of immune responses. The regulation of IL-12 production is largely at the transcriptional level (reviewed in 1). IL-1β accelerated the accumulation of IL-12β in DC, and this was also observed after LPS and IFN-γ simulation (data not shown), a signal known to increase the transcription of the IL-12α and IL-12β genes (6,27). Indeed, we show that CD40L and IL-1β increased the levels of IL-12α and IL-12β mRNA in DC, and most likely this constitutes the main mechanism responsible for the dramatic effect of IL-1β and CD40L on IL-12 secretion. Most likely IL-1β induces transcriptional activity but it is also possible that IL-1β could act by preventing the degradation of IL-12 mRNA, rather than inducing higher transcriptional activity, as this is a mechanism of action of IL-1 that has described in other hematopoietic cells (28) . Our results show for the first time that IL-1β alone results also predict that additive or synergistic effects might be obtained between IL-1β and other regulators of IL-12. We observed additive effects between LPS and IL-1β with CD40L. This could be due to additive stimulation of common intracellular signaling molecules including MyD88, IRAK and expressed IL-12β mRNA levels that were detectable in one out of three experiments (Fig. 8A) . However, DC treated with TRAF6 that activate NF-κB, and thus IL-12 transcription (29) . This could also activate separate but convergent signaling the combination of CD40L and IL-1β expressed high levels of IL-12β mRNA in three out of three experiments. Multiplex pathways, since IL-1β activates MAPK and PI3 kinase pathways, which may synergize with NF-κB to regulate gene RT-PCR was used to measure levels of IL-12α mRNA relative to 18S RNA using specific primers that interfere with 18S expression (reviewed in 30). Our results support the notion that additional signals are RNA amplification beyond the range of linearity. Results show that IL-12α mRNA levels are very low in unstimulated cells required to induce high levels of IL-12 secretion in response to CD40L stimulation (14,15). This appears to contrast with but are induced by IL-1β or CD40L, or by the combination of CD40L and IL-1β (Fig. 8B) . These results are representative previous studies indicating that CD40L alone could induce IL-12 heterodimer secretion (11,21,31). One explanation for of two separate experiments. The observed induction of IL-12α mRNA by IL-1β alone was confirmed in an additional this discrepancy may come from the use of CD40L-transfected cell lines in these studies. Small amounts of IL-1β, a cytokine third experiment. Thus, treatment of DC with the combination of CD40L and IL-1β induced high mRNA levels for both ubiquitously produced, particularly by stromal cells, may be secreted by such cell lines and small amounts could, based IL-12α and IL-12β. These results show that the mechanism for the induction of IL-12 secretion by these agents involves on our results, effectively augment the secretion of bioactive IL-12. It is also possible that CD40L in transfected cells the separate regulation of IL-12 mRNAs, with IL-1β preferentially up-regulating IL-12α mRNA and CD40L preferentially provides a stronger stimulus as a membrane-bound form than as a soluble form. Altogether, our results show that multiple up-regulating IL-12β mRNA.
signals may provide more intensity or specificity in determining the response of DC to particular maturation stimuli. Our study Discussion is consistent with the general concept that DC integrate multiple types of signals to regulate the production of high The present study identifies IL-1β as an inducer of IL-12 secretion in DC in response to CD40L and thus provides a levels of bioactive IL-12. to Listeria infection (33) . The ability to mount an immune response against high doses of Listeria requires IL-12 (34) suggesting that IL-1β may be required in a biologically References relevant manner to produce IL-12 to control some infections. 
